z-logo
open-access-imgOpen Access
Ocular Delivery of PACAP1-27 Protects the Retina From Ischemic Damage in Rodents
Author(s) -
Dóra Werling,
Dóra Reglődi,
William A. Banks,
Therese S. Salameh,
Krisztina Kovács,
Tímea Kvárik,
Alexandra Váczy,
László Kovács,
F. Mayer,
Bese Dányádi,
Emese Lokos,
Andrea Tamás,
Gábor K. Tóth,
Zsolt Bíró,
Tamás Atlasz
Publication year - 2016
Publication title -
investigative ophthalmology and visual science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.935
H-Index - 218
eISSN - 1552-5783
pISSN - 0146-0404
DOI - 10.1167/iovs.16-20630
Subject(s) - medicine , retina , ophthalmology , neuroprotection , ophthalmic artery , common carotid artery , downregulation and upregulation , retinal , ischemia , anesthesia , pharmacology , carotid arteries , chemistry , neuroscience , biology , blood flow , biochemistry , gene
Pituitary adenylate cyclase activating polypeptide (PACAP) is neuroprotective in neuronal injuries. Bilateral common carotid artery occlusion (BCCAO) causes chronic hypoperfusion-induced degeneration in the rat retina, where we proved the retinoprotective effect of intravitreal PACAP. Although this route of administration is a common clinical practice in several diseases, easier routes are clinically important. Our aim was to investigate the potential retinoprotective effects of PACAP eye drops in BCCAO-induced ischemic retinopathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom